





authors declare that no
competing interests exist.
Funding: See page 23
Received: 25 January 2016
Accepted: 12 July 2016
Published: 08 August 2016
Reviewing editor: K
VijayRaghavan, Tata Institute of
Fundamental Research, India
Copyright Voelzmann et al.
This article is distributed under
the terms of the Creative
Commons Attribution License,
which permits unrestricted use
and redistribution provided that
the original author and source are
credited.
Tau and spectraplakins promote synapse
formation and maintenance through Jun
kinase and neuronal trafficking
Andre Voelzmann1, Pilar Okenve-Ramos2, Yue Qu1, Monika Chojnowska-Monga2,
Manuela del Can˜o-Espinel3, Andreas Prokop1*, Natalia Sanchez-Soriano2*
1Faculty of Life Sciences, The University of Manchester, Manchester, United
Kingdom; 2Department of Cellular and Molecular Physiology, Institute of
Translational Medicine, University of Liverpool, Liverpool, United Kingdom;
3Instituto de Biologı´a y Gene´tica Molecular-Departamento de Bioquı´mica y Biologı´a
Molecular y Fisiologı´a, Universidad de Valladolid-CSIC, Valladolid, Spain
Abstract The mechanisms regulating synapse numbers during development and ageing are
essential for normal brain function and closely linked to brain disorders including dementias. Using
Drosophila, we demonstrate roles of the microtubule-associated protein Tau in regulating synapse
numbers, thus unravelling an important cellular requirement of normal Tau. In this context, we find
that Tau displays a strong functional overlap with microtubule-binding spectraplakins, establishing
new links between two different neurodegenerative factors. Tau and the spectraplakin Short Stop
act upstream of a three-step regulatory cascade ensuring adequate delivery of synaptic proteins.
This cascade involves microtubule stability as the initial trigger, JNK signalling as the central
mediator, and kinesin-3 mediated axonal transport as the key effector. This cascade acts during
development (synapse formation) and ageing (synapse maintenance) alike. Therefore, our findings
suggest novel explanations for intellectual disability in Tau deficient individuals, as well as early
synapse loss in dementias including Alzheimer’s disease.
DOI: 10.7554/eLife.14694.001
Introduction
The correct formation and subsequent maintenance of synapses is a key prerequisite for brain devel-
opment, function and longevity. Precocious loss of synapses is observed in late onset neurodegener-
ative diseases including Alzheimer’s disease (AD) and Frontotemporal Dementia (FTD), likely
contributing to the cognitive decline and neuronal decay observed in patients (Pooler et al., 2014;
Saxena and Caroni, 2007; Serrano-Pozo et al., 2011). Therefore, the characterisation of mecha-
nisms maintaining synapses during ageing would have major implications for our understanding of
dementias.
The development of synapses and their maintenance during ageing is dependent on sustained
transport of synaptic proteins from the distant soma, driven by motor proteins which trail along the
bundles of microtubules in axons and dendrites (Goldstein et al., 2008). Microtubules are regulated
by microtubule binding proteins which are therefore in a key position to regulate synapse formation
and maintenance (Prokop, 2013).
Tau is a microtubule associated protein (MAP) discovered in the mid-seventies
(Weingarten et al., 1975). Reduction in Tau levels has been linked to intellectual disability
(Sapir et al., 2012) and a class of brain disorders termed ’dementias which lack distinctive histopa-
thology’ (DLDH) (Zhukareva et al., 2001). Tau detachment from MTs is linked to prominent neuro-
degenerative diseases such as Alzheimer’s disease, Frontotemporal Dementia and some forms of
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Parkinson’s disease (Kovacs, 2015). In vitro, Tau has the ability to regulate microtubule properties
including stability, cross-linkage and polymerisation (Morris et al., 2013). Through such functions,
Tau would be expected to regulate multiple aspects of neuronal cell biology, but its physiological
roles are still not understood and highly debated (Morris et al., 2013). This might partly be due to
experimental challenges posed by functional redundancy, where other MAPs are proposed to mask
physiological roles of Tau (Ma et al., 2014; Takei et al., 2000).
A good model in which to deal with functional redundancy is the fruit fly Drosophila mela-
nogaster. As is ideal for studies of Tau, Drosophila neurons provide access to powerful genetics,
they are readily established for research on the neuronal cytoskeleton (Sa´nchez-Soriano et al.,
2010), on neuronal transport (Schwarz, 2013) and on synapses (Prokop and Meinertzhagen,
2006). Importantly, concepts and mechanisms gained from work in flies are often well conserved in
higher organisms (Bellen et al., 2010; Jaiswal et al., 2012).
Work in Drosophila suggested that the spectraplakin Short Stop (Shot), a large actin-MT linker
molecules and potent regulators of microtubules, could display potential functional overlap with Tau
during microtubule stabilisation (Alves-Silva et al., 2012; Prokop, 2013). This hypothesis is attrac-
tive because the well-conserved mammalian spectraplakin Dystonin is already linked to a neurode-
generative disease (type VI hereditary sensory autonomic neuropathy; OMIM
#614653;) (Ferrier et al., 2013), and its paralogue ACF7/MACF1 plays important roles during brain
development (Goryunov et al., 2010; Ka and Kim, 2015). Since ACF7 continues to be expressed in
the brain, it is tempting to speculate that it might be required for neuronal maintenance
(Bernier et al., 2000).
Here we use Drosophila neurons, in culture and in vivo alike, to demonstrate novel roles of Tau in
regulating the formation and maintenance of synapses during ageing, by coordinating the intracellu-
lar trafficking of synaptic proteins. Thus, we show that the role of Tau in synapse regulation occurs in
functional overlap with Shot. The robust shot-tau double-mutant phenotypes enabled us to study
the mechanistic cascade composed of three steps: microtubule stability as the trigger, the JNK sig-
nalling pathway as the mediator and kinesin-3 mediated axonal transport of synaptic proteins as the
key effector. We propose a new mechanism based on the loss of Tau function which could explain
intellectual disability in MAPT (the human tau gene) mutant individuals and precocious synapse loss
in tau-related neurodegeneration (Saxena and Caroni, 2007; Serrano-Pozo et al., 2011).
eLife digest Nerve cells form cable-like projections called axons that connect to other nerve
cells to form the nervous system. Axons carry nerve impulses in the form of electrical messages, and
they pass on these messages to other cells at junctions known as synapses. Specific patterns of
connections between axons allow us to coordinate our movements, feel emotions and think. In
Alzheimer’s disease and other neurodegenerative conditions, synapses often decay earlier than they
should, which can cause important connections between nerve cells to be lost.
To be able to make and maintain synapses, nerve cells transport materials from the main body of
the cell along axons to the sites where synapses form. A protein called Tau and a family of proteins
called the spectraplakins are linked to neurodegenerative diseases. Changes (or mutations) in these
proteins were known to disrupt the formation and maintenance of synapses, but it was not clear how
these proteins work in this context.
Voelzmann et al. studied Tau and spectraplakin during synapse formation and maintenance in
fruit flies. The experiments show that both proteins stabilise tube-like structures called microtubules
in axons, which provide structural support to cells. The loss of Tau or spectraplakins causes the
microtubules to fall apart and triggers an internal stress signalling pathway known as the JNK
pathway. Activating JNK signalling blocks the transport of synaptic materials along axons, which
prevents the formation of new synapses and starves existing synapses leading to their decay.
The next step is to find out whether Tau and spectraplakins play similar roles in the nerve cells of
mammals, which may open up new opportunities to develop therapies for Alzheimer’s and other
neurodegenerative diseases.
DOI: 10.7554/eLife.14694.002
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Figure 1. Tau and Shot are required for the formation of synaptic specialisations in axons. (A) Primary neurons at 2 DIV obtained from embryos that
were wildtype (wt), tau-/-, and tau-/- with elav-Gal4 driven expression of UAS-tau-GFP; neurons were stained for tubulin (Tub, red) and the synaptic
protein Synaptotagmin (Syt, light blue). (B) Quantification of the experiment shown in A, shown as the number of Syt puncta per neuron, normalised to
wildtype (the assessed numbers of neurons are indicated in each bar, ***PMW<0.001, **PMW<0.01). (C) Primary Drosophila neurons at 2DIV, obtained
from embryos that were wildtype (wt), tauMR22(tau-/-), shot3(shot-/-), and shot3 tauMR22(shot-/- tau-/-), co-stained with antibodies against HRP (magenta)
and the synaptic proteins (green) Syt and Bruchpilot (Brp); areas emboxed with dashed lines are displayed as magnified insets showing the synaptic
staining only. (D) Quantification of the experiments in C, displayed as number (no.) of Syt and Brp puncta per neuron, normalised to wildtype (the
assessed numbers of neurons are indicated in each bar, ***PMW<0.001; **PMW<0.01; *PMW<0.05,). Scale bar: 10 mm. A statistics summary of the data
shown here is available in Figure 1—source data 1.
Figure 1 continued on next page
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Results
Tau is required for the formation of synapses
To study synaptic roles of Drosophila Tau, we first used primary Drosophila neurons generated from
tau mutant embryos. Primary fly neurons are genetically and experimentally highly amenable and
provide robust cellular and subcellular readouts (Prokop et al., 2012). These cultures are also partic-
ularly suited for the study of embryonic lethal mutations since they allow the examination of neurons
beyond the embryonic lethal stage. Already 8 hr in vitro (HIV), these neurons show transport of syn-
aptic material in the growing axon (Sa´nchez-Soriano et al., 2010) and after 2 days in vitro (DIV),
they display functional presynaptic sites (Ku¨ppers-Munther et al., 2004; Ku¨ppers et al., 2003) that
can be reliably stained with antibodies against presynaptic proteins (Figure 1—figure supplement
1). They contain dense bars and synaptic vesicle accumulations which undergo excitation-dependent
uptake and release (Ku¨ppers-Munther et al., 2004; Ku¨ppers et al., 2003).
The Df(3R)tauMR22 mutation (tauMR22) is an embryonic lethal chromosome deletion that uncovers
most of the Drosophila tau gene and is a true null allele (Bolkan and Kretzschmar, 2014;
Doerflinger et al., 2003). We found that tauMR22 mutant primary neurons at 2 DIV show a decrease
in the number of puncta positive for Bruchpilot (Brp) and Synaptotagmin (Syt) (Bruchpilot/Brp: 42%;
Synaptotagmin/Syt: 59%; all compared to wildtype control neurons; Figure 1). Our finding suggest
that tau-deficient primary neurons contain fewer Brp and Syt positive presynaptic specialisations. In
the following, we will refer to this phenotype as synapse reduction.
To confirm that this reduction in synapse numbers was due to the loss of Tau, we performed res-
cue experiments using Gal4-induced neuronal expression of UAS-tau-GFP (Doerflinger et al., 2003)
in tauMR22 mutant neurons. We found a significant improvement of the tauMR22 mutant phenotype
(Figure 1A–B). We concluded that absence of Tau causes a reduction in presynaptic sites.
Tau displays functional overlap with the spectraplakin Shot
To assess potential functional overlap of Tau with the Drosophila spectraplakin Shot, we first ana-
lysed shot3 mutant primary neurons at 2 DIV. We found a reduction in synapse numbers (Brp: 62%;
Syt: 67%; Figure 1C–D), consistent with previous descriptions in vivo (Lo¨hr et al., 2002;
Prokop et al., 1998). We confirmed that this reduction in synapse numbers was due to the loss of
Shot by using Gal4-induced neuronal expression of UAS-shot-GFP (Alves-Silva et al., 2012; San-
chez-Soriano et al., 2009) which significantly rescued the synapse phenotype in shot3 mutant neu-
rons (Figure 1—figure supplement 2), confirming the involvement of Shot.
We then assessed potential functional overlap of Shot and Tau. First, we analysed primary neu-
rons double-mutant for the shot3 and tauMR22 null alleles (shot-tau) which showed even lower syn-
apse numbers (Brp: 22%; Syt: 39%; Figure 1C–D) than either of the single mutant neurons. Notably,
these analyses were performed on clearly polarised neurons with well developed axons to exclude
indirect effects caused by defective axon growth (Figure 3—figure supplement 3). Despite that, we
found that the double-mutant neurons displayed reduced branch numbers (Figure 3—figure sup-
plement 3F). However, we could demonstrate that the lower number in branches is not the cause
for synapse reduction by using knock-down experiments as well as rescue experiments (explained in
Figure 1 continued
DOI: 10.7554/eLife.14694.003
The following source data and figure supplements are available for figure 1:
Source data 1. Summary of the statistics from Figure 1B and C.
DOI: 10.7554/eLife.14694.004
Figure supplement 1. Co-localisation of presynaptic markers reveals presynaptic specialisations.
DOI: 10.7554/eLife.14694.005
Figure supplement 2. Rescue experiments with Shot and Tau demonstrate redundant roles in synapses.
DOI: 10.7554/eLife.14694.006
Figure supplement 2—source data 1. Summary of the statistics from Figure 1—figure supplement 2B.
DOI: 10.7554/eLife.14694.007
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Figure 2. Tau and Shot regulate the localisation of presynaptic proteins at the embryonic NMJ in vivo. (A) Images show the dorsal segment of inter-
segmental motornerves (Landgraf et al., 2003) in stage 16 embryos that were wildtype (wt), tauMR22 (tau-/-), shot3 (shot-/-), and shot3 tauMR22 (shot-/-
tau-/-), stained with antibodies against Syt (green) and the motorneuron-specific cell membrane protein Fasciclin II (FasII, magenta). Arrowheads depict
the distal end of the motoraxons where the nascent NMJs are forming; boxed areas are displayed as enlarged insets showing anti-Syt staining only.
Note that cell bodies of sensory neurons contain visible levels of Syt in the mutant (white arrows) but not in wildtype neurons (open arrow). (B)
Quantification of the experiments in A, shown as the average intensity of Syt at the nerve ending normalised to wildtype (the sample number of NMJs
is indicated in each bar, ***PMW<0.001; **PMW<0.01; *PMW<0.05; ns, not significant PMW>0.05). Scale bars: 10 mm. A statistics summary of the data
shown here is available in Figure 2—source data 1.
Figure 2 continued on next page
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detail below, Figure 3—figure supplement 3 and Figure 3—figure supplement 4, see also
Discussion).
In further support of functional overlap, also our genetic interaction studies revealed a synapse
reduction phenotype in shot3/+ tauMR22/+ double heterozygous mutant neurons (see later in Figure
5A). Finally, we performed cross-rescue experiments by expressing a shot transgene in tauMR22
mutant neurons and a tau transgene in shot3 mutant neurons. In both cases, Syt staining revealed a
rescue of the synapse reduction phenotype (Figure 1—figure supplement 2). Taken together, our
results indicate that Shot and Tau functionally overlap, rather than act hierarchically in the same
pathway.
Next, we investigated synaptic phenotypes in vivo. Since shot3 and tauMR22 animals are
late embryonic lethal, we analysed them at late embryonic stage 16, when Syt is already confined to
nascent synaptic terminals, as can be reliably imaged at neuromuscular junctions (NMJs; Figure 2
and Figure 2—figure supplement 1 for a schematic drawing of the embryonic NMJ)
(Littleton et al., 1993). In shot-tau mutant embryos, Syt levels at NMJs were reduced to 48%,
whereas shot mutant embryos showed a milder reduction to 71%, and tau mutant embryos no
detectable effect (Figure 2). Taken together, our data suggest that Tau is required for the formation
of synapses in culture and in vivo and that Tau and Shot functionally overlap in this context.
Synapse maintenance in the ageing brain requires Tau and Shot
Tau and Shot remain highly expressed in mature neurons (see later in Figure 6), and we tested
whether they are required also for synapse maintenance. For this, we used the GAL4-UAS system to
co-express previously used and validated UAS-RNAi constructs for both genes in the same neurons
(Bolkan and Kretzschmar, 2014; Subramanian et al., 2003). This strategy takes out Tau and Shot
functions with some delay, due to the late onset of GAL4 expression and the persistence of Tau and
Shot proteins (Figure 3—figure supplement 1).
We first used this approach in cultured primary neurons, where combined knock-down of tau and
shot caused no reduction in the number of Syt-labelled presynaptic sites at 3 and 18 DIV as com-
pared to wildtype controls (Figure 3A–B), indicating normal synapse development. However, at 26
DIV, Syt puncta in knock-down neurons were reduced to 41% (Figure 3A–B), which was comparable
to the shot-tau double-mutant phenotype at 2 DIV (Figure 1). At all time points (i.e. 3, 18 and 26
DIV), there were no measurable changes in axonal length nor in branch number when compared to
control neurons (Figure 3—figure supplement 4) clearly indicating that the strong reduction in Syt
positive synapses in 26 DIV knock-down neurons was not a secondary effect of morphological
changes such as in number of branches and axonal length (Figure 3A and B).
To assess roles in synapse maintenance also in vivo in the ageing brain, we used atonal-Gal4 (ato-
Gal4) to drive gene expression in dorsal cluster (DC) neurons of the adult brain (Zscha¨tzsch et al.,
2014) (illustrated in Figure 3—figure supplement 2). In these experiments, we expressed GFP-
tagged Synaptotagmin (Syt-GFP) to label synapses, either alone or together with shotRNAiand/or
tauRNAi. We compared young flies at 2–5 days after eclosion with old flies at 24–29 days at 29oC.
We found that the number of Syt-GFP labelled synapses in DC neurons decreased to 34% in aged
specimens expressing both shotRNAi and tauRNAi when normalised to young flies of the same geno-
type (Figure 3C–D). This age-dependent decrease in synapse numbers did not occur in control flies
(Figure 3C–D), and single knock-down of either shot or tau only showed a non-significant tendency
to lose synapses over time (Figure 3D). Notably, aged double knock-down DC neurons had no
reduction in the number of axonal branches (as assessed with the myr-tdTomato membrane marker;
Figure 3E–F), indicating that also in vivo precocious synapse decay was not due to axonal loss.
Figure 2 continued
DOI: 10.7554/eLife.14694.008
The following source data and figure supplement are available for figure 2:
Source data 1. Summary of the statistics from Figure 2B.
DOI: 10.7554/eLife.14694.009
Figure supplement 1. Schematic drawings of embryonic tissues analysed in this study.
DOI: 10.7554/eLife.14694.010
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Figure 3. Tau and Shot are required for the maintenance of synaptic markers in cultured neurons and the ageing adult fly brain. (A) Primary neurons at
3 DIV and 26 DIV cultured from embryos that were wildtype or jointly expressing UAS-tauRNAi and UAS-shotRNAi in all neurons driven by the pan-
Figure 3 continued on next page
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From our studies in culture, in embryos and in the adult brain, we conclude that Tau and Shot are
required for synapse development during early stages, and for synapse maintenance in ageing neu-
rons, where their combined deficiency causes precocious synapse loss.
Tau and Shot control intracellular trafficking of synaptic proteins
Synapse formation and maintenance require that synaptic proteins synthesised in the soma are
actively transported through the axon towards the distant presynaptic sites. In Drosophila primary
neurons, transport of endogenous synaptic proteins already starts at 8 hr in vitro (HIV) when synaptic
proteins appear as dotted patterns along axons and in growth cones (Sa´nchez-Soriano et al., 2010)
(Figure 4A–B). This is similar in rat hippocampal neurons (Bonanomi et al., 2005). Already at this
early stage, shot-tau double mutant neurons display a strong decrease in synaptic proteins in growth
cones and axons (Figure 4A–B), indicating potential intracellular transport defects.
To study intracellular transport, we analysed the dynamics of Syt-GFP using live imaging of neu-
rons at 8 HIV. In shot-tau mutant neurons, the percentages of anterograde and retrograde displace-
ments and retrograde velocities of Syt-GFP containing vesicles were not affected and anterograde
velocities were only slightly increased. In contrast, the number of Syt vesicles within the axon showed
a sharp decrease to ~40% in shot-tau mutant neurons when compared to controls (Figure 4C). Nota-
bly, this decrease in axonal vesicles is accompanied by an increase in the number of somatic Syt-GFP
puncta to ~159% (Figure 4C). Similarly, endogenous Syt was increased in somata of shot-tau mutant
neurons, both in culture and in in vivo (Figure 4D–E).
These phenotypes in shot-tau mutant neurons suggested aberrant intracellular trafficking of Syt-
containing vesicles, potentially due to a road block in the soma.
Figure 3 continued
neuronal driver elav-Gal4 (tauRNAi shotRNAi). Neurons are stained with anti-tubulin and anti-Syt; at 26 DIV, tauRNAi shotRNAi neurons display a reduction in
the number of Syt puncta when compared to wildtype. (B) Quantification of the experiments in A, shown as the number of Syt puncta per neuron at 3
DIV, 18 DIV and 26 DIV, normalised to wildtype controls (the number of assessed neurons is indicated in each bar; ***PMW<0.001; ns, not significant
PMW>0.05). (C) A region of Drosophila adult brains including the medulla (delimited by dashed lines) where Syt-GFP is expressed in dorsal cluster
neurons using atonal-Gal4, in the absence (control) or together with tauRNAi and shotRNAi (tauRNAi shotRNAi). Brains are stained with anti-GFP at 2–5 days
(young) and 24–29 days (old) after eclosion. Note that GFP-labelled synapses (arrowheads) are decreased in old brains upon shot and tau knock-down.
(D) Quantification of the experiments in C, showing the normalised number of Syt-GFP-labelled puncta in old specimen per mean number of puncta in
young specimens for the following phenotypes: ato-Gal4 UAS-syt-GFP alone (control), co-expressing UAS-tauRNAi (tauRNAi), UAS-shotRNAi(shotRNAi), or
both knock-down constructs (tauRNAi shotRNAi; the number of analysed brains is indicated in each bar, ***PMW<0.001; ns, not significant PMW>0.05). (E)
Brain regions as in C, of animals expressing the membrane marker myr-tdTomato driven by ato-Gal4 revealing the morphology of the projections of
dorsal cluster neurons within the medulla ; brains were from adults at 2–5 days (young) and 24–29 days (old) after eclosure, expressing myr-tdTomato
either alone (control) or together with tauRNAi and shotRNAi(tauRNAi shotRNAi). (F) Quantification of the experiments in E, displayed as number of
branches per axon projecting into the medulla (the number of axons analysed is indicated in each bar; ns, not significant PMW>0.05). Scale bar: 10 mm in
A and 40 mm in C and E. A statistics summary of the data shown here is available in Figure 3—source data 1.
DOI: 10.7554/eLife.14694.011
The following source data and figure supplements are available for figure 3:
Source data 1. Summary of the statistics from Figure 3B,D,F.
DOI: 10.7554/eLife.14694.012
Figure supplement 1. Delayed effect of RNAi mediated knock-down of Shot and Tau.
DOI: 10.7554/eLife.14694.013
Figure supplement 1—source data 1. Summary of the statistics from Figure 3—figure supplement 1B.
DOI: 10.7554/eLife.14694.014
Figure supplement 2. Schematic drawings of brain areas analysed in this study.
DOI: 10.7554/eLife.14694.015
Figure supplement 3. Loss of function mutations in shot and tau induce morphological changes.
DOI: 10.7554/eLife.14694.016
Figure supplement 4. RNAi-mediated knock-down of Shot and Tau has no effect on axonal length and branch number.
DOI: 10.7554/eLife.14694.017
Figure supplement 4—source data 1. Summary of the statistics from Figure 1—figure supplement 3C and D.
DOI: 10.7554/eLife.14694.018
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Figure 4. Intracellular transport of synaptic proteins is defective in shot-tau mutant neurons. (A) Primary Drosophila neurons at 8HIV, obtained from
embryos that were wildtype (wt) and shot-tau (shot-/- tau-/-) stained with antibodies against pan-neuronal HRP (magenta), Syt (green) or nSyb (green);
Figure 4 continued on next page
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Tau and Shot regulate the activity of kinesin-3
Type 3 kinesins are the predominant motors driving axonal transport of synaptic proteins
(Hirokawa et al., 2010). This is also the case for the Drosophila homologue Unc-104 (also called
Imac) (Pack-Chung et al., 2007). We found that unc-104170 null mutant primary neurons at 2 DIV
have a vast reduction of Syt-stained synapses (Figure 5A). This phenotype is strikingly similar to the
one observed in shot-tau mutant neurons, and suggested that Shot-Tau might regulate Unc-104
function.
To test this hypothesis, we performed genetic interaction studies. We found that primary neurons
stained for Syt at 2 DIV and heterozygous for all of the three genes (shot-/+ unc-104-/+ tau-/+) dis-
played significant reduction in the number of Syt-stained synapses when compared to heterozygous
condition of the unc-104 or shot-tau mutant alleles alone (Figure 5A). Also triple-heterozygous
mutant embryos at late stage 16 displayed reduced Syt staining at neuromuscular terminals, but
increased staining in the cell bodies of CNS and sensory neurons (Figure 5C; see Figure 2—figure
supplement 1 for a schematic drawing of the embryonic NMJ and CNS). Therefore, unc-104170
mutant, shot-tau mutant, and triple-heterozygous mutant neurons all show similar phenotypes, both
in culture and in vivo, suggesting a functional link between these three proteins.
Type 3 kinesins are anterograde motor proteins that move towards axon tips in mouse neurons
(Niwa et al., 2013), and we also find Drosophila Unc-104 to be distally enriched in the axons of pri-
mary neurons at 2 DIV and in embryonic motorneurons in vivo (Figure 5D–E). In mouse, this distal
localisation was shown to be suppressed when blocking kinesin-3 mobility (Niwa et al., 2013). Also
in shot-tau mutant neurons in culture and in vivo, Unc-104 localisation in distal axons is reduced
whereas levels in the somata are increased (Figure 5D–E), suggesting that insufficient amounts of
Unc-104 move from the somata into axons.
To test whether diminished Unc-104 levels in axons are the cause for the synaptic defects in shot-
tau mutant conditions, we over-expressed Unc-104, which fully restored synapse numbers in shot-
tau mutant neurons at 2 DIV (Figures 5B versus 1D). Notably, Unc-104 over-expression in shot-tau
mutant neurons achieved this rescue of synapses in neurons with significantly less axonal branches
(Figure 3—figure supplement 3F), clearly demonstrating that both features are regulated indepen-
dently of each other.
We next examined whether Unc-104 plays comparable roles also during synapse maintenance in
the ageing brain. We used the ato-Gal4 driver (Zscha¨tzsch et al., 2014) and co-expressed Unc-104
together with shotRNAi and tauRNAi. To label synapses we expressed the presynaptic marker neuronal
Synaptobrevin-GFP (nSyb-GFP, due to technical reasons the use of nSyb-GFP was more convenient
than Syt-GFP). Consistent with our previous findings with Syt-GFP (Figure 3C–D), also nSyb-GFP
Figure 4 continued
nSyb and Syt are reduced in the growth cones (open versus white arrow heads) but enriched in cell bodies (open versus white arrows) of shot-tau
mutant neurons. (B) Quantification of the experiments from A, given as the number of nSyb or Syt puncta in axons and growth cones; the number of
analysed neurons is given in the bars (***PMW<0.001). (C) Quantification of various transport parameters generated from live movies of axons of
wildtype or shot-tau mutant neurons (shot-/- tau-/-) at 8 HIV with elav-Gal4 driven expression of UAS-Syt-GFP. Axonal anterograde and retrograde
velocities show only subtle or no alteration in the axons of shot-tau neurons. On the contrary, the numbers of vesicles in axons of shot-tau neurons are
sharply decreased and increased in the somata (**PMW<0.01; *PMW<0.05; ns, not significant PMW>0.05). (D) Magnified views of the somata from primary
Drosophila neurons at 2 DIV, obtained from wildtype (wt) and shot-tau mutant embryos (shot-/- tau-/-), co-stained with antibodies against Syt. To
document the protein content within cell bodies, several z stacks per neuron were obtained and fused as maximal projection; the cell bodies show
higher levels of Syt in shot-tau mutant neurons as compared to wildtype (number of assessed cells is indicated in the bars, average staining intensity
normalised to wildtype; ***PMW<0.001). (E) The dorsal peripheral nervous system (PNS) of wildtype andshot-tau embryos at late stage 16 (stages
according to) (Campos-Ortega and Hartenstein, 1997) stained for Syt (green), FasII (red) and the pan-neuronal nuclear marker Elav (blue). The nascent
NMJ at the tip of the inter-segmental motornerve (red) in wildtype contains high levels of Syt (white arrow) whereas the somata of sensory neurons
(blue and grey in insets) contain low levels (open arrow); in shot-tau homozygous embryos the somata of sensory neurons have high levels of Syt (arrow
and inset), whereas there is only little staining at the nerve tip (open arrowhead). Scale bars: 10 mm in A, 5 mm in D and 5 mm in E. A statistics summary
of the data shown here is available in Figure 4—source data 1.
DOI: 10.7554/eLife.14694.019
The following source data is available for figure 4:
Source data 1. Summary of the statistics from Figure 4B–D.
DOI: 10.7554/eLife.14694.020
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Figure 5. Defects in kinesin-3 function mediate synaptic deficits in shot-tau mutant neurons. Shot and Tau interact with Unc-104 and regulate its
subcellular distribution. (A) Primary Drosophila neurons at 2 DIV, obtained from embryos which were wildtype, homozygous for unc104imac170 (unc104-/-),
Figure 5 continued on next page
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revealed age-dependent synapse reduction upon shotRNAi and tauRNAi expression, clearly confirming
our previous data (Figure 5—figure supplement 1 and 8E–F). When Unc-104 was co-expressed,
synapse reduction was clearly rescued (Figure 5—figure supplement 1).
Taken together, our data are consistent with a model where Shot-Tau loss generates a road block
which inhibits Unc-104 translocation from the soma into axons, causing synaptic defects at develop-
mental stages and in ageing neurons.
Loss of Shot-Tau induces microtubule destabilisation accompanied by
changes in JNK activation
To address the mechanistic links from loss of Shot-Tau to aberrant transport and synaptic defects,
we focussed on microtubules. Shot localises along microtubules, and shot mutant neurons treated
with the microtubule-destabilising drug nocodazole display unusual gaps in their axonal microtubule
bundles (Figure 6B–C) (Alves-Silva et al., 2012; Sanchez-Soriano et al., 2009). Tau also localises
along microtubules (Figure 6A, Video 1), and tauMR22 mutant neurons likewise displayed axonal
microtubule gaps upon nocodazole treatment which could be rescued with targeted expression of
Tau (Figure 6B–C). Both, shot and tau mutant neurons treated with nocodazole displayed on aver-
age one gap per axon. This number is significantly increased to ~3 gaps in shot-tau mutant neurons
(Figure 6B–C), demonstrating that Tau and Shot share a common function in microtubule
stabilisation.
To test whether their roles in microtubule stabilisation and synapse regulation are linked, we
treated shot-tau mutant embryos at early stage 16 for 3 hr with the microtubule-stabilising drug
epothilone B (Goodin et al., 2004). We found a significant rescue of Syt levels at motoraxonal end-
ings, which was not observed in vehicle-treated controls (Figure 6D–E). Therefore, a decrease in
microtubule stability is a likely cause for defective transport of synaptic proteins in shot-tau mutant
neurons. It could be argued that Shot-Tau dependent microtubule stabilisation directly regulates
processive advance of kinesins in axons (see Discussion), yet the rather normal transport dynamics
Figure 5 continued
or triple-heterozygous for shot3 tauMR22 unc104imac170 mutations (shot+/- tau+/-unc104+/-), co-stained with antibodies against tubulin (Tub, magenta) and
Syt (green). The graph shows the quantification of the data including also unc104-/+ and shot-/- tau-/- controls. (B) Quantification of Syt puncta in two
day old neurons, obtained from embryos that were wildtype or shot-/- tau-/- with elav-Gal4 driven expression of UAS-unc-104 (compare Figure 1D). (C)
The dorsal peripheral nervous system (PNS) and the central nervous system (CNS) of wildtype and shot3 tauMR22 unc104imac170 triple heterozygous
embryos at late stage 16 (stages according to Campos-Ortega and Hartenstein, 1997) stained for Syt (green), FasII (red in upper panel) and the pan-
neuronal nuclear marker Elav (blue); for illustration of the imaged tissue see Figure 2-figure supplement 1. The nascent NMJ at the tip of the inter-
segmental motornerve (red in upper panels) in wildtype contains high levels of Syt (arrowheads) whereas the somata of sensory neurons (blue;
demarcated by dashed lines) contain low levels (open arrows); in shot3 tauMR22 unc104imac170 triple heterozygous embryos the somata of sensory
neurons have high levels of Syt (arrows), whereas there is only little staining at the nerve tip (open arrowhead). In the ventral nerve cord of wildtype
(lower panels), Syt is confined to the neuropile (synapse containing CNS compartment; arrowheads) and excluded from the cortex (compartment with
the cell bodies of inter- and motorneurons); in the ventral nerve cord of shot3 tauMR22 unc104imac170 triple heterozygous embryos, there are segmental
groups of cell bodies displaying higher Syt levels (arrows). (D) Primary Drosophila neurons at 2 DIV, obtained from wildtype (wt) and tau-shot mutant
embryos, stained with antibodies against pan-neuronal HRP (magenta) and Unc-104 (green); Unc-104 in distal axon segments (emboxed and magnified
in insets) is enriched in wildtype but much weaker in shot-tau mutant neurons (chevrons indicate neuronal somata). Data were quantified as average
intensity of Unc-104 at the distal end of the axon divided by the average intensity at the soma. (E) Upper and lower panels show the same locations of
late stage 16 embryos as shown in C, but taken from wildtype and shot-tau mutant embryos, stained for FasII (magenta) and Unc-104 (green). Note the
stark decrease of Unc-104 at the end of motor nerves (open versus white arrow heads) and the unusual accumulations of Unc-104 in the cell bodies of
sensory neurons as well as in the CNS cortex in shot-tau embryos (open versus white arrows). In all graphs, the number of assessed neurons is indicated
in each bar; ***PMW<0.001; *PMW<0.05; ns, not significant PMW>0.05; scale bars: 18 mm in A, 5 mm in C/PNS, 35 mm in C/CNS, 15 mm in D and E/PNS,
35 mm in E/CNS. A statistics summary of the data shown here is available in Figure 5—source data 1.
DOI: 10.7554/eLife.14694.021
The following source data and figure supplements are available for figure 5:
Source data 1. Summary of the statistics from Figure 5.
DOI: 10.7554/eLife.14694.022
Figure supplement 1. Expression of Unc-104 rescues synaptic defects in aged adult brains.
DOI: 10.7554/eLife.14694.023
Figure supplement 1—source data 1. Summary of the statistics from Figure 5—figure supplement 1B.
DOI: 10.7554/eLife.14694.024
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Figure 6. Microtubule instability mediates aberrant JNK signalling and synaptic defects. (A) Live imaging of Drosophila neurons at 2 DIV, obtained from
embryos carrying tau304 (a protein trap line where the endogenous tau gene is genomically tagged with GFP) and the microtubule binding protein
Jupiter-Cherry. Endogenous Tau (in magenta) is observed in a pattern reminiscent of microtubules, and colocalises with Jupiter (shown in green). (B)
Axons of Drosophila neurons at 6 HIV with the following genotypes: wildtype (wt), shot3 (shot-/-), tauMR22 (tau-/-), tau rescue (tau-/- UAS-tau) and shot-tau
(shot-/- tau-/-). Neurons were treated for 2.5 hrs with vehicle (DMSO) or 20 mM nocodazole, fixed and stained with anti-Tubulin (Tub, magenta and white)
Figure 6 continued on next page
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we observed upon live imaging in shot-tau mutant neurons clearly excluded this possibility
(Figure 4C).
Instead, we hypothesised that microtubule aberration indirectly promotes a transport roadblock
in somata. As a potential mediator, we suspected the JNK signalling pathway which is known to
respond to a number of cellular stresses (see Discussion). To test our hypothesis, we investigated
the pattern of JNK activity, using an antibody against phosphorylated JNK (JNK-P) (Langen et al.,
2013). In wild type embryos at stage 16, we found high accumulations of JNK-P at motoraxon tips
and low levels in the somata of CNS and sensory neurons (Figures 6F and 7A), i.e. a localisation pat-
tern similar to that of synaptic proteins and Unc-104 (Figure 5C–E). This distribution was altered in
single tauMR22 or shot3 mutant embryos, showing higher levels of JNK-P in neuronal somata and
lower levels at the tips of motoraxons (Figure 7A). This altered pattern was intensified in shot-tau
double mutant neurons (Figure 7A) and clearly reminiscent of the redistribution patterns observed
with synaptic proteins and Unc-104 in these neu-
rons (Figures 4E and 5E). Notably, these changes
in the pattern of JNK activation were reproduced
when inducing microtubule stress by applying
nocodazole to early stage 16 wildtype embryos
(Figure 6F). Complementary to this finding, treat-
ment of shot-tau mutant neurons with the micro-
tubule stabilising drug epothilone B, increased
the localisation of JNK-P at axonal tips and
reduced the aberrant localisation in somata (Fig-
ure 6—figure supplement 1A,B).
These data suggested a cascade of events
where shot-tau mediated microtubule destabilisa-
tion or stress triggers abnormal JNK activation in
somata which, in turn, causes a somatic block of
Unc-104 mediated synaptic transport. In strong
support of this hypothesis, the three key players
of this cascade, JNK-P, Unc-104 and synaptic
proteins, show a striking correlation by concen-
trating unanimously at axon tips in wildtype, but
in somata in shot-tau mutant neurons
(Figures 4E, 5E and 7A).
Figure 6 continued
and phalloidin (Pha, green). Only shot3, tauMR22, and shot-tau double mutant displayed gaps in their axonal microtubule bundles upon nocodazole
treatment, but not wildtype and tau mutant embryos with Tau rescue. (C) Quantification of the experiments in B, indicated as the number of breaks in
the microtubule staining per axon (number of analysed neurons is indicated in bars; ***PMW<0.001; **PMW<0.01; ns, not significant PMW>0.05). (D)
Embryonic motoraxons of wildtype and shot-tau embryos at late stage 16 treated with vehicle (DMSO) or 50 nM of the microtubule stabilising drug
epothilone B for 3 hr and stained with FasII (magenta) and Syt (green); in wildtype, the nascent NMJ at the nerve tip contains high levels of Syt
(arrowheads); in shot-tau embryos there is only little Syt staining at the nerve tip (open arrowhead). Treatment of shot-tau embryos with 50nM
epothilone B increases the levels of Syt at the tip of motornerves (arrowheads). (E) Quantification of the experiments shown in D, measured as the
average intensity of Syt at nascent NMJs and normalised to wildtype (number or assessed NMJ is indicated in bars; ***PMW<0.001; ns, not significant
PMW >0.05). (F) Upper (PNS) and lower (CNS) panels show the same locations of late stage 16 wildtype embryos as shown in Figure 5C, stained for
FasII (magenta) and activated phospho-JNK (JNK-P); treatment with 100 mm nocodazole for 2 hrs induced a relocation of JNK-P from nascent NMJs
(open versus white arrow heads) to cell bodies of sensory neurons and in the CNS cortex (white versus open arrows). Scale bar: 5 mm in A, 4 mm in B, 10
mm in E, 15 mm in D/PNS and 35 mm in D/CNS. A statistics summary of the data shown here is available in Figure 6—source data 1.
DOI: 10.7554/eLife.14694.025
The following source data and figure supplements are available for figure 6:
Source data 1. Summary of the statistics from Figure 6C and E.
DOI: 10.7554/eLife.14694.026
Figure supplement 1. Treatment of shot-tau mutant neurons with epothilone B, increases the localisation of JNK-P at axonal tips.
DOI: 10.7554/eLife.14694.027
Figure supplement 1—source data 1. Summary of the statistics from Figure 6—figure supplement 1B.
DOI: 10.7554/eLife.14694.028
Video 1. Live imaging of Drosophila neurons at 2 DIV,
obtained from embryos carrying tau304 (a protein trap
line where the endogenous tau gene is genomically
tagged with GFP) and the microtubule binding protein
Jupiter-Cherry. Endogenous Tau (in green) is observed
in a pattern reminiscent of microtubules, and
colocalises with Jupiter (shown in red). The time laps
were obtained every 15 s with a 3i Marianas Spinning
Disk Microscope.
DOI: 10.7554/eLife.14694.029
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Aberrant JNK signalling upon Shot-Tau loss causes the somatic road-
block of Kinesin-3 transport and synaptic defects
To prove that JNK acts downstream of shot-tau to regulate Unc-104, we first expressed a constitu-
tively active variant of the MAPKK Hemipterous (HepAC), a known activator of the JNK pathway
(Glise et al., 1995). In late stage 16 embryos, indiscriminate JNK activation through HepAC triggered
an accumulation of Unc-104 and Syt in somata and a decrease of both proteins at axon tips
(Figure 7B–C). Also in primary mature neurons at 2 DIV, HepAC caused a reduction in the number of
synapses to 43% (Figure 8A–B). Therefore, HepAC expression mimicked the defects observed in
Figure 7. Activated JNK correlates with the subcellular localisation of Unc-104 and Syt. Upper (PNS) and lower (CNS) panels in A-C show the same
locations of late stage 16 embryos as shown in Figure 5E, but embryos are of different genotypes and stained with different antibodies, as indicated;
genotypes: wildtype (wt), shot3 (shot-/-), tauMR22 (tau-/-), shot-tau (shot-/- tau-/-), elav-Gal4 driven expression of UAS-hepac (UAS-hepac); used antibodies
detect FasII (magenta), Syt (green), Unc-104 (green), activated phospho-JNK (JNK-P). (A) In wildtype, JNK-P is high at nerve endings (white arrow heads)
and below detection levels in cell bodies of sensory neurons and in the CNS cortex (open arrows); this pattern is inverted in tauMR22 and shot3 mutant
embryos and even stronger in shot-tau embryos, i.e. Syt is reduced at nerve endings (open arrowheads) and upregulated in cell bodies (white arrows).
(B, C) Artificial activation of JNK with neuronal expression of Hepac suppresses high levels of Unc-104 and Syt at nascent NMJs (open versus white arrow
heads) and increases their levels in cell bodies (white versus open arrows). Scale bars: 15 mm in PNS panels and 35 mm in CNS panels.
DOI: 10.7554/eLife.14694.030
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shot-tau mutant neurons, consistent with a model where aberrant JNK pathway activation upon
Shot-Tau loss causes the somatic block of Unc-104-dependent synaptic transport.
If our model is correct, attenuation of the JNK pathway should rescue the synaptic defects in
shot-tau mutant neurons. To downregulate the JNK pathway, we used loss-of-function of the JNK
activating kinase Wallenda/DLK (wnd2) (Valakh et al., 2013) and overexpression of the JNK inhibit-
ing phosphatase Puckered (Puc) (Martin-Blanco et al., 1998). When combined with the tauMR22
mutation, both genetic tools for JNK downregulation fully rescued the synaptic defects in primary
neurons at 2 DIV (Figure 8A–B). Even more, wnd2 fully rescued synapse reduction in shot-tau double
mutant neurons at 2 DIV (Figure 8A–B), and Syt levels at NMJs of shot-tau mutant embryos in vivo
(Figure 8C–D versus Figure 2).
So far, our data suggest that JNK acts downstream of shot-tau to regulate Unc-104. In this case,
attenuation of the JNK pathway should also rescue aberrant Unc-104 localisation in shot-tau mutant
neurons. Accordingly, wnd2 restored correct localisation of Unc-104 in shot-tau double mutant neu-
rons at 2 DIV (Figure 8—figure supplement 1), and in shot-tau mutant embryos in vivo (Figure 8—
figure supplement 2B versus Figure 5D,E).
Having confirmed JNK as the essential mediator of shot-tau synaptic defects, we tested whether
it acts through the canonical pathway involving the AP1 transcription factor (Ciapponi and Boh-
mann, 2002), or by phosphorylating other targets in the cytoplasm. For this, we used a well estab-
lished LOF mutant allele of the kayak/c-fos gene (kay2) which removes one constituent of the AP1
heterodimer and mimics various known JNK mutant phenotypes (Ciapponi and Bohmann, 2002).
Unlike wnd2 or Puc overexpression, the kay2 mutation failed to rescue the synaptic phenotypes of
tauMR22 in primary neurons (Figure 8A–B). This strongly suggests that the JNK pathway inhibits syn-
aptic transport by acting independently of AP1 dependent transcription.
In conclusion, the JNK pathway is both required and sufficient to mediate between Shot-Tau loss
and their downstream synaptic phenotypes in developing neurons by causing a transport roadblock,
and this likely occurs through phosphorylating cytoplasmic targets in the soma.
JNK mediates ageing related synaptic decay caused by Shot-Tau loss
To test whether JNK plays comparable roles also during synapse maintenance in the ageing brain,
we used the ato-Gal4 driver (Zscha¨tzsch et al., 2014) and co-expressed a dominant negative variant
of the Drosophila JNK homolog Basket (bskDN) (Adachi-Yamada et al., 1999) together with shotR-
NAi, tauRNAi and nSyb-GFP. We found that co-expression of bskDN was able to rescue the synapse
reduction phenotype (Figure 8E,F), thus confirming JNK as a mediator between the effects of shot-
tau and precocious synapse decay also in ageing neurons (summarised in Figure 9).
Discussion
A new mechanism of synaptic pathology caused by loss of Tau and Shot
The aim of our studies was to understand the role of endogenous Tau in neurons with particular
attention to synapses. This effort was essentially aided by our finding that Tau and Shot are function-
ally redundant, and the subsequent incorporation of Shot into our studies. The robust phenotypes of
shot-tau double-mutant neurons enabled us to demonstrate roles of Shot-Tau during the formation
and maintenance of pre-synaptic sites in axons, and unravel the underlying mechanistic cascade
which involves three major steps. Firstly, the absence of Shot-Tau causes microtubule destabilisation.
Secondly, this cytoskeletal stress causes aberrant JNK activity patterns with upregulation in somata
and downregulation at axon tips. Thirdly, aberrant JNK activation leads to a somatic roadblock for
kinesin-3 mediated transport, thus inhibiting the delivery of synaptic proteins and eventually causing
synapse loss. Depending on whether the functions of Tau and/or Shot are removed during develop-
ment or ageing, either the formation or the maintenance of synapses are affected,
respectively (Figure 9).
Our model explaining the function of Tau and Shot in synapse establishment and maintenance by
regulating intracellular transport, is supported by loss- and gain-of-function experiments, genetic
interactions and cross-rescue experiments. The initial finding that shot-tau mutant neurons had
reduced branch numbers, could have suggested that defects on synapse numbers is indirect. How-
ever, experiments with double knock-down in culture and in the adult brain clearly showed strong
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Figure 8. Inhibition of the JNK pathway rescues synaptic defects in shot-tau mutant neurons. (A) Primary Drosophila neurons at 2 DIV, obtained from
embryos of the following genotypes: wildtype (wt), elav-Gal4 driven expression of UAS-hepac (UAS-hepac), tauMR22 (tau-/-), wnd2 (wnd-/-), tau-/- with elav-
Figure 8 continued on next page
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synapse reduction whilst maintaining normal branch patterns, and Unc-104 rescued synapse reduc-
tion in shot-tau mutant neurons without major increases of the branch pattern in these neurons.
These results clearly demonstrate that changes in neuronal morphology are not the cause of changes
in synapse number.
Notably, the synaptic function of Tau described here for Drosophila might be conserved in higher
animals or humans, since also aged Tau knock-out mice develop a reduction of synaptic proteins
from the hippocampus (Ma et al., 2014).
Implications of our findings for Tau-related pathologies
Our findings provide potential new mechanistic explanations for various tau related brain disorders.
For example, microdeletions in the region of MAPT (the human tau gene) cause intellectual disability
(Sapir et al., 2012), and Tau’s synapse-promoting roles m ay well contribute to this pathology. Fur-
thermore, various tauopathies are characterised by precocious pathological loss of synapses. Our
data suggest that loss of tau could lead to defective synapse maintenance and eventually synapse
loss. For example, a prominent group of dementias which lacks distinctive histopathology (DLDH)
are characterised by the loss of Tau (Zhukareva et al., 2001). Further tauopathies including Alz-
heimer disease, typically involve hyper-phosphorylation and aggregate formation of Tau
(Herna´ndez and Avila, 2007; Williams, 2006). In this scenario, there are two parallel, non-exclusive
modalities through which Tau can cause pathology. Firstly, detached hyper-phosphorylated tau
attains gain-of-function roles in the cytoplasm damaging neurons through a number of mechanisms
(Morris et al., 2013). Secondly, hyper-phosphorylation of tau causes a loss-of-function condition by
depleting Tau from microtubules. However, since Tau knock-out mouse models mostly failed to
show significant phenotypes and the neuronal functions of endogenous tau remain little understood,
the pathological importance of Tau loss from microtubules has been marginalised (Morris et al.,
2013). Our results now re-emphasise the notion that loss of Tau from microtubules could contribute
to neurodegenerative pathology and deliver mechanistic explanations.
To unravel pathomechanisms caused by the loss of Tau, we mostly used combined depletion of
Shot and Tau, which gave us strong phenotypes, ideal for short-term experimental approaches.
However, we found similar, yet milder phenotypes if only Tau was depleted, suggesting that the
mechanisms described here could well contribute to slow disease progression in tauopathies. Our
discovery that spectraplakins are MAPs which functionally overlap with Tau, opens up new
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Gal4 driven expression of UAS-puc (tau-/- UAS-puc), tauMR22 kay2 (tau-/- kay-/-) and shot3 tauMR22 wnd2 (shot-/- tau-/- wnd-/-), all stained with antibodies
against Tubulin (tub, magenta) and Syt (green). Insets correspond to emboxed areas and show a magnified view of the Syt staining. (B) Quantification
of experiments in A, shown as the number of Syt puncta normalised to wildtype (number of assessed neurons is shown in the bars, ***PMW<0.001;
**PMW<0.01; *PMW<0.05; ns, not significant PMW>0.05). (C) Inter-segmental motornerves in the dorsal area of wildtype and shot
3 mutant embryos at late
stage 16, stained against FasII (magenta) and Syt (green); insets correspond to emboxed areas and show a magnified view of the most dorsal nascent
NMJs stained for Syt; note the rescue of Syt localisation if Wnd is absent in tau-shot mutant background. (D) Quantification of the experiments in C,
measured as the average intensity of Syt normalised to wt (number of assessed NMJs is shown in the bars; ***PMW<0.001; *PMW<0.01). (E) A region of
Drosophila adult brains including the medulla; UAS-nSyb-GFP is expressed in dorsal cluster neurons using atonal-Gal4, either alone (control), together
with tauRNAi and shotRNAi (tauRNAi shotRNAi) or together with tauRNAi, shotRNAi and UAS-bskDN. Brains are shown at 2–6 days (young) and 26–30 days at
29˚C after eclosion (old); GFP-labelled synapses are decreased in old brains with shot-tau knock-down when compared to controls, and this effect is
rescued by the expression of BskDN. (F) Quantification of experiments in E, shown as number of GFP-labelled synapses in old specimen per mean
number of GFP-labelled synapses in young specimens of the respective genotype (number of analysed brains is indicated in the bars; ***PMW<0.001;
**PMW<0.01). Scale bars: 5 mm in A, 10 mm in C and 40 mm in E. A statistics summary of the data shown here is available in Figure 8—source data 1.
DOI: 10.7554/eLife.14694.031
The following source data and figure supplements are available for figure 8:
Source data 1. Summary of the statistics from Figure 8B,D and F.
DOI: 10.7554/eLife.14694.032
Figure supplement 1. Attenuation of the JNK pathway rescues aberrant Unc-104 localisation in shot-tau mutant neurons in culture.
DOI: 10.7554/eLife.14694.033
Figure supplement 1—source data 1. Summary statistics from Figure 8—figure supplement 1B.
DOI: 10.7554/eLife.14694.034
Figure supplement 2. Attenuation of the JNK pathway rescue aberrant unc-104 localisation in shot-tau mutant embryos.
DOI: 10.7554/eLife.14694.035
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experimental avenues for Tau studies. So far, spectraplakins have been linked to the degeneration
of sensory and autonomous neurons (Edvardson et al., 2012; Ferrier et al., 2013), and it remains
to be elucidated whether they may have similar roles also in the brain. Our results clearly hint at this
possibility.
A novel mechanism for Tau-dependent regulation of neuronal transport
The loss of Tau and/or Shot inhibits kinesin-3 mediated transport leading to accumulation of synaptic
proteins in the soma of neurons. We propose a road-block mechanism suppressing the initiation of
axonal transport in somata of Shot-Tau depleted neurons, which is caused indirectly through micro-
tubule stress and mediated by JNK (Figure 9).
The involvement of microtubules in causing a transport block is supported by our experiments
using microtubule stabilising and de-stabilising drugs which rescued or mimicked the shot-tau
mutant phenotypes, respectively. Similarly, axonal transport defects and cognitive deficits of PS19Tg
mice (expressing the P301S mutant form of human tau) and various other mouse and fly tauopathy
models were shown to be rescued by microtubule-stabilising drugs (Gozes, 2011; Quraishe et al.,
2013; Shemesh and Spira, 2011; Zhang et al., 2012), suggesting that the mechanisms we
described may be conserved and relevant to disease.
The somatic road-block is a novel mechanism through which the loss of Tau can interfere with the
transport of synaptic proteins and provides potential explanations also for somatic accumulations of
postsynaptic proteins such as PSD-95, AMPA and NMDA receptors observed in mouse tauopathy
models (Hoover et al., 2010; Shao et al., 2011). A likely mechanism causing a roadblock in intracel-
lular transport could be the direct inactivation of Unc-104 or its associated adaptor proteins, for
example through JNK or other kinases within its pathway. This mode of regulation has a clear
Figure 9. Schematic model of proposed function for Tau and Shot. (A) Neurons illustrating different phenotypes: in wildtype neurons (wt), microtubules
are stable (green line) and levels of Unc-104 (red square), synaptic markers (yellow dots) and p-JNK (turquoise background) are high in axon tips; in
shot-tau mutant neurons, microtubules are unstable (stippled green lines), and the above listed proteins accumulate in cell bodies (soma); ubiquitous
activation of JNK ("JNK) causes similar somatic accumulation of Unc-104 and synaptic markers; down-regulation of JNK (#JNK) rescues the shot-tau
mutant phenotypes. (B,C) Schematic representation of the underlying mechanisms: In wildtype neurons (B), Unc-104 is activated (Unc*) and mediates
axonal transport of synaptic proteins (yellow arrow) to the axon tip, where we propose (?) that active JNK inhibits Unc-104, thus releasing its cargo for
synaptic incorporation. In shot-tau mutant neurons (C), unstable microtubules cause upregulation of JNK in the soma, thus inhibiting Unc-104 and
trapping it as well as its cargo proteins in the soma.
DOI: 10.7554/eLife.14694.036
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precedent in kinesin-1 and its adaptor Jip which are directly phosphorylated by JNK leading to
transport inhibition (Stagi et al., 2006). Unfortunately, our extensive attempts to co-immunoprecipi-
tate JNK and Kinesin-3 were unsuccessful (data not shown), leaving open for now the exact molecu-
lar mechanism.
JNK is an important mediator between shot-tau induced microtubule
stress and synapse loss
We propose that aberrant JNK activation downstream of microtubule destabilisation or stress is the
ultimate cause for the defective delivery of synaptic proteins in Tau and/or Shot loss of function.
Also in mouse, microtubule stress leads to somatic activation of the JNK pathway, suggesting this
mechanism is likely to be conserved with vertebrates (Valakh et al., 2015).
The JNK pathway is emerging as a central player in neurodegenerative diseases. Its activation is
prompted by various neurodegeneration risk factors including oxidative stress, inflammation, and
ageing (Lotharius et al., 2005; Valakh et al., 2015). Furthermore, JNK is activated in AD patients
(Coffey, 2014) and in several AD models where it triggers progression of the pathology
(Sclip et al., 2014). The new link between Tau/spectraplakins, JNK and synapses we propose here,
is therefore likely to provide mechanistic explanations for synaptic pathology observed in AD and
other tauopathies.
Conclusions
We have delivered an important conceptual advance by revealing a new mechanistic cascade which
can explain synaptic decay as the consequence of Tau loss from microtubules. Furthermore, we iden-
tified a previously unknown functional redundancy with spectraplakins as a promising new avenue
for research on Tau. Our findings emphasise that Tau detachment from microtubules can be an
important aspect contributing to the pathology of tauopathies in parallel to roles of hyper-phosphor-
ylated Tau in the cytoplasm. Synaptic decay, axonal transport and alterations in the JNK pathway
are emerging as central players in a wider range of adult-onset neurodegenerative diseases, and
here we have aligned these factors into a concrete mechanistic cascade.
Materials and methods
Fly stocks
The following fly stocks were used: the Gal4 driver lines sca-Gal4 (Sa´nchez-Soriano et al., 2010),
elav-Gal4 (3rd chromosome) (Luo et al., 1994) and ato-Gal4 (Zscha¨tzsch et al., 2014); the mutant
alleles Df(3R)tauMR22 (Bolkan and Kretzschmar, 2014; Doerflinger et al., 2003), shot3
(Kolodziej et al., 1995), unc-104imac170 (courtesy of Dr. T. Schwarz) (Pack-Chung et al., 2007), wnd2
(Collins et al., 2006) and kay2 (Ciapponi and Bohmann, 2002) (the latter two courtesy of S. Swee-
ney); the UAS lines UAS-tau-GFP (Doerflinger et al., 2003), UAS-shot-GFP (Alves-Silva et al., 2012;
Sanchez-Soriano et al., 2009). tauGD25023 (UAS-tauRNAi; Vienna Drosophila RNAi Center, Austria)
(Bolkan and Kretzschmar, 2014), UAS-shotRNAi (Subramanian et al., 2003), UAS-syt-GFP (3rd and
2nd chromosome, Bloomington Stock Center), UAS-nSyb-GFP (Bloomington Stock Center), UAS-
tdTomato (Zscha¨tzsch et al., 2014), tau304 (Bloomington Stock Center), Jupiter-Cherry (Blooming-
ton Stock Center), UAS-Hep-ac (Glise et al., 1995), UAS-bskDN (Adachi-Yamada et al., 1999) and
UAS-puc (Martin-Blanco et al., 1998) (the latter five fly stocks courtesy of B. Hassan). Lethal fly
stocks were kept over balancers carrying twist-Gal4 and UAS-GFP constructs (Halfon et al., 2002),
and combinations of mutant alleles and transgenic constructs were generated using conventional
genetic crosses (Prokop, 2013).
Cell culture
The generation of primary neuronal cell cultures was described previously (Prokop et al., 2012; Sa´n-
chez-Soriano et al., 2010). In brief, to generate Drosophila primary cultures, neurons were extracted
from stage 11 embryos (Campos-Ortega and Hartenstein, 1997). Whole embryos were treated for
1 min with bleach to remove the chorion, sterilized for ~30 s in 70% ethanol, washed in sterile
Schneider’s/FCS, and eventually homogenized with micro-pestles in 1.5 ml tubes containing about
21 embryos per 100 ml dispersion medium. This was followed by 4–5 min incubation in dispersion
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buffer containing collagenase and dispase at 37˚C, followed by a wash in sterile Schneider’s/FCS
and eventually resuspension in the final volume of Schneider’s medium. Cells were plated onto cov-
erslips coated with 0.5 mg/ml Concanavalin A (Sigma) and kept as hanging drop cultures in air-tight
special culture chambers (Ku¨ppers-Munther et al., 2004) usually for 8 hr, 2–3, 18 or 26 days at
26˚C. Dilutions of the MT destabilising drug nocodazole (20 mM; Sigma) in Schneider’s medium were
prepared from stock solutions in DMSO. For controls, equivalent concentrations of DMSO were
diluted in Schneider’s medium.
Drug treatment of Drosophila embryos
Stage 16 embryos were dissected flat in D ulbecco’s Phosphate Buffered Saline (Budnik et al.,
2006) and cultured for several hours in Schneider’s medium with or without drugs. Dilutions of the
microtubule destabilising drug nocodazole (20 mM; Sigma) and the microtubule stabilizer epothilone
B (50 nM; Sigma) in Schneider’s medium were prepared from stock solutions in DMSO. For controls,
equivalent concentrations of DMSO were diluted in Schneider’s medium.
Immunohistochemistry
Primary fly neurons were fixed in 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB; pH 7–
7.2) for 30 min at room temperature (RT). Stage 16 embryos were dissected flat in Dulbecco’s Phos-
phate Buffered Saline (Budnik et al., 2006) and fixed with 4% PFA for 30 min. Adult fly brains were
dissected in Dulbecco’s Phosphate Buffered Saline and fixed with 4% PFA for 15 min. Antibody
staining and washes were performed with Phosphate Buffered Saline supplemented with 0.3% Triton
X-100. Staining reagents: anti-Tubulin (clone DM1A, mouse, Sigma; alternatively, clone YL1/2, rat,
Millipore Bioscience Research Reagents); anti-FasII (clone ID4, mouse, DSHB, RRID: AB_532376);
anti-GFP (goat, Abcam RRID: AB_305643); Cy3/FITC-conjugated anti-HRP (goat, Jackson ImmunoR-
esearch); anti-Syn (SYNORF1 3C11, mouse, DSHB, RRID:AB_528479); anti-Brp (DSHB, RRID:AB_
2314867); anti-Syt (rabbit, was a gift from Dr. S. Sweeney); anti-nSyb and anti-Unc104 (both rabbit,
were a gift of Dr. T. Schwarz); anti-Elav (rat, DSHB, RRID:AB_528218); anti-pJNK (rabbit, pTPpY,
Promega, RRID:AB_430864), anti-CD2 (mouse, AbD Serotec, RRID:AB_566608), anti-dTau (Nick
Lowe), anti-Shot (Talila Volk) FITC-, Cy3- or Cy5-conjugated secondary antibodies (donkey, purified,
Jackson ImmunoResearch). Specimens were embedded in Vectashield (VectorLabs).
Microscopy and data analysis
Standard documentation was performed with AxioCam monochrome digital cameras (Carl Zeiss
Ltd.) mounted on BX50WI or BX51 Olympus compound fluorescent microscopes. Z-stacks of embry-
onic CNSs were taken with a Leica DM6000 B microscope and extracted with Leica MM AF Premier
software. Z-stacks of adult fly brains were taken with a Leica DM6000 B microscope or with a 3i
Marianas Spinning Disk Confocal Microscope. Using custom software written in Python and NumPy,
fly brain images taken with a Leica DM6000 B microscope were individually band-pass filtered (A
trous wavelet [1][2], linear 3x3 filter, keeping scales 1–4) to remove stationary background.
To quantify the number of synaptic densities in mature neurons in culture and the number of
vesicles containing synaptic proteins in 8h neurons in culture, we used ImageJ (RRID:SCR_003070).
In detail, we used thresholding to select synaptic densities from axons of single isolated cells, fol-
lowed by particle analysis. For all experiments done in parallel, identical thresholds were used. For
the quantification of synapses in mature neurons in culture, we selected polarised neurons with a
clear distinguishable axon, the same neurons were used to study axon length and number of
branches.
To quantify synaptic proteins or Unc-104 in the soma of neurons, we manually selected the area
of the somata using the tubulin or HRP channel and measured the signal intensity derived from the
Syt or Unc-104 channel. To measure the levels of Unc-104 at the tip of axons, we selected an area of
the same size at the most distal part of axons and measured the signal intensity derived from the
Unc-104 channel. To quantify synaptic proteins at the tip of embryonic motorneurons in vivo. we
manually selected the area occupied by the growth cones using the FasII staining and measured the
signal intensity derived from the Syt channel; the background intensity was subtracted. Images used
for these measurements did not contain saturated levels. Also, to measure the number of synaptic
densities in DC neurons in the medulla of the adult brain, we used thresholding to select synaptic
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densities followed by particle analysis. The number of branches in the medulla per DC neuron was
quantified manually. To quantify MT stability upon nocodazole treatment, we counted the number
of breaks in the microtubule bundle per axon.
Time lapse imaging of cultured primary neurons (in Schneider’s/FCS) was performed on a Delta
Vision RT (Applied Precision) restoration microscope using a 100x/1.3 Ph3 Uplan Fl objective and
the Sedat filter set (Chroma 89000). The images were collected using a Coolsnap HQ (Photometrics)
camera. The temperature control was set to 26˚C. For time lapse recording, images were taken
every 2 s for 2 min. To generate transport measurements, vesicles containing fluorescently tagged
Syt were tracked manually using the manual tracking plugin for ImageJ.
Statistics, replicates and sample-size
All data are shown as mean with SEM. Statistical analyses were performed in GraphPad Prism using
Mann-Whitney Rank Sum Tests (indicated as PMW) or Chi
2 (PChi), with 95% confidence intervals. The
exact p-values and sample size are indicated in the figure legends.
For each primary neuronal cell culture experiment (technical replication), approximately 30 to 40
embryos were used. Neurons obtained from those embryos were divided and cultured in 3 to 4
independent chambers (biological replication). The sample size provided corresponds to the number
or neurons studied. Most experiments were performed at least 2 times (2 technical repeats) meaning
a minimum of 60 embryos were used, and a minimum of 6 independent culture chambers were stud-
ied. These experiments are shown in Figure 1B (tau-/-, 4 technical replications, 11 biological replica-
tions), Figure 1D (Syt, shot-/-, 3 technical replications, 9 biological replications; shot-/- tau-/-, 3
technical replications, 9 biological replications), Figure 1D (Brp shot-/-, 2 technical replications, 8 bio-
logical replications; tau-/- 2 technical replications, 6 biological replications), Figure 3B (all genotypes
at each time point 2 technical replications, 6–8 biological replications), Figure 4D (all genotypes 2
technical replications, 6 biological replications), Figure 5B (2 technical replications, 6 biological repli-
cations), Figure 8B (tau-/- Uas-Puc, 3 technical replications, 8 biological repeats; tau-/- wnd-/-, 2 tech-
nical replications, 6 biological repeats; shot-/- tau-/- wnd-/-, 2 technical replications, 6 biological
replications). Other experiments were as follows: UAS-tau rescue experiment of synaptic defects
(Figure 1B) and microtubule stability defects (Figure 6C) in tau-/- were performed with 1 technical
replication which included at least 30 embryos distributed in 4 and 2 independent chambers or bio-
logical replications, respectively. However, for these particular experiments we used a co-culture
technique in which tau-/-control neurons were cultured alongside with tau-/- UAS-Tau neurons and
therefore are subject to the same environmental variations. For shot-tau mutant neurons stained
with Brp (Figure 1D) we used 1 technical replication which included at least 30 embryos and 3 inde-
pendent biological replications. For tau-/- kay-/- and kay-/- (Figure 8B), we used 1 technical replica-
tion which included at least 30 embryos and 5 independent biological replications. For the
measurement of Syt and nSyb synaptic puncta in 8 HIV neurons (Figure 4B), we performed 1 techni-
cal replication for each synaptic protein, which included at least 30 embryos each and 2 independent
biological replications. For the measurement of Unc-104 in 2 day neurons (Figure 5D) we performed
1 technical replication which included at least 30 embryos and 45 neurons were measured. To
account for variations in the immunohistochemistry procedure, we calculated the ratio between dis-
tal axon and soma.
For the quantification of axonal transport (Figure 4C), we performed 2 technical replications
which included at least 30 embryos each, 2 independent biological replications from which 10–14
neurons were analysed. For measurements of Syt in the nascent embryonic NMJ (Figure 2B and
8C) we used at least 15 embryos per genotype (biological replication) and performed at least 2 tech-
nical replications. Both controls and mutant embryos were dissected and stained in the same cham-
ber and therefore subjected to equal conditions (Figure 2B shot-/- 3 technical replications, 30
biological replications, tau-/- 2 technical replications, 15 biological replications, shot-/- tau-/- 3 techni-
cal replications, 17 biological replications; Figure 8C shot-/- tau-/-wnd-/- 2 technical replications, and
15 biological replications). For treatment of embryos with epothilone B (Figure 6E) we used at least
12 embryos per genotype and performed 2 technical replications. Both controls and shot-tau mutant
embryos were present in the same treatment chambers and therefore subjected to equal conditions.
For the study of synaptic phenotypes in adult brains (Figure 3D), we performed at least 3 techni-
cal replications and used a minimum of 30 brains in total per genotype. For the quantification of axo-
nal branches in adult brains we performed at least 2 technical replications and we used a minimum
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of 11 brains. For rescues of synaptic phenotypes in adult brains with UAS-bskDN (Figure 8F) we per-
formed 3 technical replications and used a minimum of 40 brains in total.
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